Panacea Announces Launch of New Product COVID CBDA(TM)
"Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the...
Year: 2022
Med-X Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
LOS ANGELES CA / ACCESSWIRE / January 18, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions...
9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer
Formerly served as VP of Finance and Commercial Operations at Biogen with 20+ years of business and strategic financial leadership...
MCOA Subsidiary cDistro Signs Distribution Agreement with Award Winning Realize Hemp Drinks
LOS ANGELES, CA / ACCESSWIRE / January 18, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), a...
Celcuity Receives FDA Fast Track Designation for Gedatolisib in HR+ / HER2- Metastatic Breast Cancer and Provides Corporate Update
FDA's Fast Track Designation for the pan-PI3K/mTOR inhibitor highlights potential to address the urgent need for new treatment options for...
Neutra’s VIVIS Excited to Release New Gummy!
KATY, TX / ACCESSWIRE / January 18, 2022 / Neutra Corp. (OTC PINK:NTRR) continues plans for Phase-1 clinical trials regarding...
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology
ORLANDO, FL / ACCESSWIRE / January 18, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced an expanded product development pipeline for its...
1933 Industries Signs Binding Letter of Intent to Acquire Beverage Company Day One
1933 Industries Signs Binding Letter of Intent to Acquire Beverage Company Day OneVANCOUVER, BC / ACCESSWIRE / January 18, 2022...
NuGen M.D. Announces a $333,000, 5-Year Distribution Agreement with Intermediq for its InsuJet(TM) Needle-Free Injection Device
TORONTO, ON / ACCESSWIRE / January 18, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) ("NuGen M.D." or the "Company") is...
NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Chronic Chemotherapy Induced Peripheral Neuropathy (CIPN) with its Wearable Neurostimulation Technology
WOBURN, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell® technology has received...
Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent
Company identifies unique two-part extraction and transdermal delivery processVANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp....
Research Finds All-Cause Hospitalizations are Nearly Three Times More Likely During a Diabetic Foot Ulcer Episode
All-cause mortality is 50% more likely during this common diabetes complicationSOMERVILLE, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Podimetrics, a...
Truepill Launches COVID-19 Test Coverage Platform to Help Insurance Companies and Group Health Plans Meet Direct Coverage Requirements
First-of-its-kind platform provides a turnkey solution to reduce costs and increase access to testingSAN MATEO, Calif., Jan. 18, 2022 (GLOBE...
Taconic Biosciences Adds New Humanized Immune System (HIS) Model to Its Portfolio For Immuno-Oncology Research
New huNOG-EXL EA Model Extends Study Windows SignificantlyRENSSELAER, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader...
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler)
Brazil Phase 2 Pulmonary Long-Hauler clinical trial of COVI-MSC is now authorized to proceed.The study will compare therapy using mesenchymal...
Turning Point Therapeutics Provides Updates and Anticipated 2022 Clinical and Discovery Pipeline Milestones
Strong enrollment within multi-cohort TRIDENT-1 Phase 2 registration enabling study of repotrectinib; completion of targeted 60 patients within EXP-4 ROS1+...
Praxis Precision Medicines Announces Publication of Preclinical Data Highlighting Differentiated and Potent Antiepileptic Activity of PRAX-562
PRAX-562 demonstrated robust preclinical antiseizure activity and exhibited an improved preclinical tolerability profile compared to standard-of-care Praxis expects to initiate...
Revelation Biosciences Inc. Announces First Patient Enrolled and Dosed in Phase 1b Clinical Study of REVTx-99 for the Treatment of Allergic Rhinitis
SAN DIEGO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life...
Shineco, Inc. Enters Into Share Transfer Agreements to Acquire 51% Equity Interest in Xiang Peng You Kang (Beijing) Technology Co., Ltd.
BEIJING, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
Healthy Extracts Reports Preliminary Q4 2021 Gross Revenue up 72% Sequentially to a Record $770,000; Full Year 2022 on Track to more than Double to over $3.3 Million
LAS VEGAS, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based...